Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur J Surg Oncol ; 41(3): 386-91, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25554680

RESUMO

BACKGROUND: Malignancies of the peritoneum remain a challenge in any hospital that accepts to manage them, due not only to difficulties associated with the complexity of the procedures involved but also the costs, which - in Italy and other countries that use a diagnosis-related group (DRG) system - are not adequately reimbursed. MATERIAL AND METHODS: We analyzed data relative to 24 patients operated on between September 2010 and May 2013 with special regard to operating room expenditure, ICU stay, duration of hospitalization, and DRG reimbursement. The total costs per patient included clinical, operating room, procedure, pathology, imaging, ward care, allied healthcare, pharmaceutical, and ICU costs. RESULTS: Postoperative hospital stay, drugs and materials, and operating room occupancy were the main factors affecting the expenditure for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. We had a median hospitalization of 14 days, median ICU stay of 2.4 days, and median operating room occupancy of 585 min. The median expenditure for each case was € 21,744; the median reimbursement by the national health system € 8,375. CONCLUSIONS: In a DRG reimbursement system, the economic effort in the management of patients undergoing peritonectomy procedures may not be counterbalanced by adequate reimbursement. Joint efforts between medical and administration parties are mandatory to develop appropriate treatment protocols and keep down the costs.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/economia , Carcinoma/economia , Neoplasias Colorretais/economia , Custos de Cuidados de Saúde , Hipertermia Induzida/economia , Mesotelioma/economia , Neoplasias Epiteliais e Glandulares/economia , Neoplasias Ovarianas/economia , Neoplasias Peritoneais/economia , Pseudomixoma Peritoneal/economia , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma/secundário , Carcinoma/terapia , Carcinoma Epitelial do Ovário , Estudos de Coortes , Neoplasias Colorretais/patologia , Custos e Análise de Custo , Cuidados Críticos/economia , Procedimentos Cirúrgicos de Citorredução/economia , Grupos Diagnósticos Relacionados/economia , Feminino , Hospitalização/economia , Humanos , Infusões Parenterais/economia , Itália , Tempo de Internação/economia , Masculino , Mesotelioma/secundário , Mesotelioma/terapia , Pessoa de Meia-Idade , Neoplasias Epiteliais e Glandulares/patologia , Duração da Cirurgia , Neoplasias Ovarianas/patologia , Neoplasias Peritoneais/secundário , Neoplasias Peritoneais/terapia , Peritônio/cirurgia , Pseudomixoma Peritoneal/terapia , Procedimentos Cirúrgicos Operatórios/economia
2.
Pacing Clin Electrophysiol ; 21(2): 465-7, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9507551

RESUMO

Spinal cord stimulation (SCS) is currently used to treat peripheral vascular disease (PVD) and refractory angina pectoris not amenable to revascularization. In a case of contemporaneous SCS implant and permanent cardiac pacemaker (PPM), if multipolar electrodes are used it is possible to avoid any interference between the systems. We describe the case of a patient with a DDD pacemaker, in whom two bipolar SCSs were implanted at different times: one to control refractory angina pectoris and the other for PVD. No interference between the three systems has been observed.


Assuntos
Angina Pectoris/terapia , Estimulação Cardíaca Artificial/métodos , Terapia por Estimulação Elétrica/métodos , Marca-Passo Artificial , Doenças Vasculares Periféricas/terapia , Idoso , Angina Pectoris/complicações , Eletrodos Implantados , Segurança de Equipamentos , Humanos , Masculino , Doenças Vasculares Periféricas/complicações , Medula Espinal
3.
Cardiologia ; 40(6): 399-405, 1995 Jun.
Artigo em Italiano | MEDLINE | ID: mdl-8640852

RESUMO

The spinal cord stimulation is an antalgic technique which has been used since 1967 for the treatment of several painful syndromes. More recently it was employed in the cardiology field to treat refractory angina, not suitable for revascularization. We applied spinal cord stimulation as alternative therapy in 7 clients older than 70 years who, for different reasons, could not undergo revascularization. We obtained good short- and long-term clinical results, without complications. On the basis of our preliminary experience with this technique in a small group of elderly patients and after a critical review of the literature, we conclude that spinal cord stimulation can be used without significant risks, in elderly patients with refractory angina pectoris.


Assuntos
Angina Pectoris/terapia , Terapia por Estimulação Elétrica , Idoso , Idoso de 80 Anos ou mais , Angina Pectoris/fisiopatologia , Contraindicações , Terapia por Estimulação Elétrica/efeitos adversos , Feminino , Humanos , Masculino , Efeito Placebo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA